Akash Tewari

Stock Analyst at Jefferies

(0)
# 4116
Out of 5,249 analysts
65
Total ratings
37.14%
Success rate
-4.66%
Average return
29 Stocks
Name Action Price Target Current % Upside Ratings Updated
Bristol-Myers Squibb
Upgrades: Buy
63 70
59.15 18.34% 3 Dec 16, 2024
Biomarin Pharmaceuti...
Initiates Coverage On: Outperform
95
62.12 52.93% 2 Nov 15, 2024
BioNTech
Upgrades: Buy
96 150
121.96 22.99% 3 Sep 17, 2024
Relay Therapeutics
Upgrades: Buy
11 16
4.89 227.2% 3 Sep 10, 2024
Neurocrine Bioscienc...
Maintains: Strong Buy
177 189
147.39 28.23% 2 Aug 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
80 80
30.71 160.5% 2 Jul 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
29 75
34.42 117.9% 1 Jul 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
994 1015
765.8 32.54% 6 Jun 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
42 50
31.7 57.73% 5 Apr 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
37 75
40 87.5% 4 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
31
21.67 43.05% 1 Dec 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
32 40
18.17 120.14% 2 Dec 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
935 937
694.38 34.94% 4 Nov 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 12
1.96 512.24% 2 Nov 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
38 39
26.45 47.45% 2 Oct 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
49 18
5.54 224.91% 2 Aug 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
497 513
652.38 -21.36% 2 Jul 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
4.64 287.93% 1 Jun 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
125
96.58 29.43% 1 Mar 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
8 11
14.82 -25.78% 1 Dec 20, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
30 4
5.8 -37.93% 2 Dec 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
17
5.7 198.25% 1 Dec 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
6 4
n/a n/a 2 Nov 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
68 69
n/a n/a 3 Aug 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
75
47.77 57% 2 Oct 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
151
339.97 -55.58% 1 Oct 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
28
34.16 -18.03% 2 Oct 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
180
n/a n/a 2 Oct 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
107
n/a n/a 1 Mar 12, 2021